Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries

Author： Kaufmann Gilbert R   Smith Don   Bucher Heiner C   Phanuphak Praphan   Sendi Pedram P   Mbidde Edward K   Cooper David A   Battegay Manuel  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.9, 2002-09, pp. : 1303-1313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Helping developing countries to benefit from pharmacogenomics

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 403, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Out-licensing drugs to enhance access in developing countries

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 398, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection

By Wyatt Christina M   Klotman Paul E  

Expert Opinion on Drug Safety, Vol. 5, Iss. 2, 2006-03 ,pp. : 275-287

Informa Healthcare

Access to resources Recommend Favorite

Low-Cost Anti-HIV Compounds: Potential Application for AIDS Therapy in Developing Countries

By  

Current Pharmaceutical Design, Vol. 9, Iss. 18, 2003-07 ,pp. : 1419-1431

Bentham Science Publishers

Access to resources Recommend Favorite

A global framework to improve access to medicines in developing countries should be established

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 347, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite